Daily feed · SEC Form 4 filings
Significant insider purchases — Sep 26, 2018
Open-market purchases of at least $50,000 — or at least $500,000 when the buyer is a 10% owner.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2018 PForm 4 → | Sep 25, 8:41 pm EDT | Y-mAbs Therapeutics, Inc.YMAB | James HealyDirector | 500,000 | $16.00 | $8,000,000 | 2,104,278 | +31.2% | plan? |
| Sep 25, 2018 PForm 4 → | Sep 26, 9:42 am EDT | Select Interior Concepts, Inc.SIC | Solace Capital Partners, L.P. +310% Owner | 500,000 | $10.20 | $5,100,000 | 4,036,439 | +14.1% | plan? |
| Sep 21, 2018 PForm 4 → | Sep 25, 5:15 pm EDT | GCP Applied Technologies Inc.GCP | Dalbergia Investments LLC +510% Owner | 84,298 | $26.36 | $2,222,388 | 3,790,407 | +2.27% | plan? |
| Sep 21, 2018 PForm 4 → | Sep 25, 4:18 pm EDT | Molecular Templates, Inc.MTEM | David HirschDirector, 10% Owner | 365,000 | $5.50 | $2,007,500 | 3,261,535 | +12.6% | plan? |
| Sep 21, 2018 PForm 4 → | Sep 25, 4:43 pm EDT | Molecular Templates, Inc.MTEM | Longitude Capital Partners III, LLC +310% Owner | 365,000 | $5.50 | $2,007,500 | 3,261,535 | +12.6% | plan? |
| Sep 25, 2018 PForm 4 → | Sep 26, 9:19 am EDT | GOLUB CAPITAL INVESTMENT Corpno symbol | Ohio Strs10% Owner | 127,608 | $15.00 | $1,914,123 | 16,528,357 | +0.78% | plan? |
| Sep 25, 2018 PForm 4 → | Sep 25, 5:57 pm EDT | REVLON INC /DE/REV | Ronald O PerelmanDirector, 10% Owner | 35,000 | $21.50 | $752,374 | 45,002,130 | +0.08% | plan? |
| Sep 21, 2018 PForm 4 → | Sep 25, 4:32 pm EDT | Griffin-American Healthcare REIT IV, Inc.no symbol | Danny ProskyPresident & COO | 53,146 | $9.65 | $512,859 | 109,379 | +94.5% | plan? |
| Sep 25, 2018 PForm 4 → | Sep 25, 4:37 pm EDT | Y-mAbs Therapeutics, Inc.YMAB | Moller San Pedro Claus JuanChief Executive Officer, Director | 31,250 | $16.00 | $500,000 | 872,928 | +3.71% | plan? |
| Sep 21, 2018 PForm 4 → | Sep 25, 9:00 pm EDT | Select Interior Concepts, Inc.SIC | Nadeem MoizChief Financial Officer | 10,000 | $10.18 | $101,800 | 10,000 | — | plan? |
| Sep 21, 2018 PForm 4 → | Sep 25, 7:02 pm EDT | TITAN PHARMACEUTICALS INCTTNP | Marc RubinExecutive Chairman, Director | 400,000 | $0.25 | $100,000 | 556,317 | +256% | plan? |
| Sep 26, 2018 PForm 4 → | Sep 26, 3:11 pm EDT | FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUNDFPL | James MurchieOther | 10,000 | $9.40 | $93,950 | 27,000 | +58.8% | plan? |
| Sep 26, 2018 PForm 4 → | Sep 26, 2:36 pm EDT | GUGGENHEIM STRATEGIC OPPORTUNITIES FUNDGOF | Randall C BarnesDirector | 3,950 | $20.55 | $81,173 | 27,287 | +16.9% | plan? |
| Sep 21, 2018 PForm 4 → | Sep 25, 7:06 pm EDT | TITAN PHARMACEUTICALS INCTTP | Sunil BhonsleSee Remarks, Director | 300,000 | $0.25 | $75,000 | 435,578 | +221% | plan? |
| Sep 25, 2018 PForm 4 → | Sep 25, 4:22 pm EDT | Francesca's Holdings CORPFRAN | Martyn R RedgraveDirector | 15,000 | $3.93 | $58,950 | 70,353 | +27.1% | plan? |
| Sep 21, 2018 PForm 4 → | Sep 25, 7:00 pm EDT | TITAN PHARMACEUTICALS INCTTNP | Joseph A AkersDirector | 200,000 | $0.25 | $50,000 | 213,000 | +1,538% | plan? |
| Sep 21, 2018 PForm 4 → | Sep 25, 7:04 pm EDT | TITAN PHARMACEUTICALS INCTTNP | James R McNabDirector | 200,000 | $0.25 | $50,000 | 300,000 | +200% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.